NCT04261504

Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Completed NA Results posted Last updated 29 May 2024

What this trial tests

NA trial testing IBMT in Multiple Drug Use in 70 participants. Completed in 28 February 2023.

Timeline

19 April 2019

Primary endpoint
28 February 2023

28 February 2023

Quick facts

Lead sponsor	Texas Tech University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	70
Start date	19 April 2019
Primary completion	28 February 2023
Estimated completion	28 February 2023
Sites	1 location across United States

Drugs / interventions tested

• IBMT
• RT

Conditions studied

• Multiple Drug Use — all drugs for Multiple Drug Use →

Sponsor

Texas Tech University

Who can join

Adults 18 to 23, any sex, with Multiple Drug Use. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Brain Changes in Functional Activity Primary · The outcome measure is assessed at baseline and post-intervention.

70 participants with polysubstance use are assessed by changes of brain in functional activity of anterior cingulate cortex before (baseline) and post-intervention (2 weeks).

Baseline

Group	Value	95% CI
Integrative Body Mind Training (IBMT)	0.7	± 1.2
Relaxation Training (RT)	0.6	± 1.3

Post-Intervention

Group	Value	95% CI
Integrative Body Mind Training (IBMT)	1.3	± 1.1
Relaxation Training (RT)	0.9	± 2.2

Sponsor's own description

The proposed study will examine brain mechanisms of a brief mindfulness intervention - integrative body-mind training (IBMT) on alcohol, tobacco, and cannabis (ATC) reduction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.